biotechnology | Science and Enterprise

A clinical trial began enrolling participants to collect real world evidence on a digital therapy designed to relie… https://t.co/AMuUt4C0oh
about 18 hours ago
New post on Science and Enterprise: Trial Underway Assessing Insomnia Therapy App https://t.co/qmdNHoo382 #Science #Business
about 18 hours ago
This week's report shows a marked increase in activity on therapies, while the number of vaccines in development an… https://t.co/Z7P2ivWaxJ
about 1 day ago
New post on Science and Enterprise: Covid-19 Vaccines, Therapies – 13 July 2020 https://t.co/epfuGPmjdy #Science #Business
about 1 day ago
This is nuts. Manufacturing, distribution, and public health infrastructure here are more important than who made t… https://t.co/AOHVdFBlrX
about 2 days ago

Pharma Companies Form $1B Antibiotics Fund

By Alan, on July 9th, 2020%

A group of 23 pharmaceutical companies are creating an investment fund to finance research and development of new drugs to combat antibiotic resistance. . . . → Read More: Pharma Companies Form $1B Antibiotics Fund

EC, France Fund Universal Covid-19, Flu Vaccines

By Alan, on July 8th, 2020%

A biotechnology company is receiving European Commission and French government funds to develop vaccines that protect against all strains of Covid-19 and flu viruses. . . . → Read More: EC, France Fund Universal Covid-19, Flu Vaccines

BARDA to Buy $2B in Covid-19 Vaccines, Therapies

By Alan, on July 7th, 2020%

The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials. . . . → Read More: BARDA to Buy $2B in Covid-19 Vaccines, Therapies

FDA Halts Off-the-Shelf Engineered T-Cell Trial

By Alan, on July 7th, 2020%

A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died. . . . → Read More: FDA Halts Off-the-Shelf Engineered T-Cell Trial

Dual Antibodies in Trial to Prevent Covid-19 Infections

By Alan, on July 6th, 2020%

A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infections, while also in a trial as a treatment for the disease. . . . → Read More: Dual Antibodies in Trial to Prevent Covid-19 Infections

Biotech IDs Potent Covid-19 Antibodies

By Alan, on July 2nd, 2020%

A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Biotech IDs Potent Covid-19 Antibodies

Crispr Heart Therapy Demonstrated in Monkeys

By Alan, on June 29th, 2020%

An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease. . . . → Read More: Crispr Heart Therapy Demonstrated in Monkeys

Trial to Test Stem Cells for Covid-19 Prevention

By Alan, on June 26th, 2020%

A company that collects and stores a person’s own stem cells for therapies later on says FDA cleared a clinical trial of donated stem cells to prevent Covid-19 infections. . . . → Read More: Trial to Test Stem Cells for Covid-19 Prevention

Gene, Cell Therapy Start-Up Gains $700M in Early Funds

By Alan, on June 23rd, 2020%

A biotechnology company creating engineered cells with modified genes for treating disease is raising $700 million in its first venture finance round. . . . → Read More: Gene, Cell Therapy Start-Up Gains $700M in Early Funds

Gut Microbe Drug Shown to Prevent Return Infections

By Alan, on June 19th, 2020%

Early results from a clinical trial show an oral drug taken one time prevents more recurring infections from harmful gut bacteria than conventional treatments. . . . → Read More: Gut Microbe Drug Shown to Prevent Return Infections

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise